Healthcare Value Capital as of Dec. 31, 2020
Portfolio Holdings for Healthcare Value Capital
Healthcare Value Capital holds 17 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Abbvie (ABBV) | 12.6 | $3.8M | 35k | 107.14 | |
| Glaxosmithkline Sponsored Adr | 12.4 | $3.7M | 100k | 36.80 | |
| Vyne Therapeutics Com New | 10.6 | $3.2M | 2.0M | 1.58 | |
| Gilead Sciences (GILD) | 9.8 | $2.9M | 50k | 58.26 | |
| Tyme Technologies | 8.9 | $2.7M | 2.2M | 1.22 | |
| Antares Pharma | 6.7 | $2.0M | 500k | 3.99 | |
| McKesson Corporation (MCK) | 5.9 | $1.7M | 10k | 173.90 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 5.6 | $1.7M | 10k | 165.10 | |
| Amarin Corp Spons Adr New Call Option (AMRN) | 4.9 | $1.5M | 300k | 4.89 | |
| Cardinal Health (CAH) | 4.5 | $1.3M | 25k | 53.56 | |
| Clovis Oncology | 4.0 | $1.2M | 250k | 4.80 | |
| Moderna Put Option (MRNA) | 3.5 | $1.0M | 10k | 104.50 | |
| Greenlane Hldgs Cl A | 3.3 | $990k | 250k | 3.96 | |
| Proshares Tr Ii Vix Sh Trm Futrs Call Option | 2.3 | $687k | 50k | 13.74 | |
| Novavax Com New Put Option (NVAX) | 1.9 | $558k | 5.0k | 111.60 | |
| Adamas Pharmaceuticals | 1.5 | $433k | 100k | 4.33 | |
| Gamida Cell SHS (GMDA) | 1.4 | $420k | 50k | 8.40 |
